13F HOLDINGS REPORT
Deep Track Capital, LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001856083-24-000002
Total Value
$3.49B
Positions
66
Other Managers
0
Confidential Omitted
No
Holdings (66)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 3,479,853 | $171.3M | 4.91% |
| 2 | AMGEN INC | AMGN | 550,000 | $156.4M | 4.48% |
| 3 | APOGEE THERAPEUTICS INC | APGE | 2,323,456 | $154.4M | 4.42% |
| 4 | INSMED INC | INSM | 4,783,679 | $129.8M | 3.72% |
| 5 | DYNE THERAPEUTICS INC | DYN | 4,555,383 | $129.3M | 3.70% |
| 6 | ALNYLAM PHARMACEUTICALS INC | ALNY | 832,310 | $124.4M | 3.56% |
| 7 | GUARDANT HEALTH INC | GH | 6,000,000 | $123.8M | 3.55% |
| 8 | ARGENX SE | ARGX | 300,000 | $118.1M | 3.38% |
| 9 | INTELLIA THERAPEUTICS INC | NTLA | 4,210,784 | $115.8M | 3.32% |
| 10 | OCULAR THERAPEUTIX INC | OCUL | 12,721,460 | $115.8M | 3.32% |
| 11 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 9,141,660 | $113.4M | 3.25% |
| 12 | AXSOME THERAPEUTICS INC | AXSM | 1,304,721 | $104.1M | 2.98% |
| 13 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 1,500,000 | $103.8M | 2.97% |
| 14 | GERON CORP | GERN | 30,505,929 | $100.7M | 2.88% |
| 15 | AUTOLUS THERAPEUTICS PLC | AUTL | 15,272,172 | $97.4M | 2.79% |
| 16 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 3,034,453 | $96.7M | 2.77% |
| 17 | ALKERMES PLC | ALKS | 3,500,000 | $94.7M | 2.71% |
| 18 | BICYCLE THERAPEUTICS PLC | BCYC | 3,490,506 | $86.9M | 2.49% |
| 19 | PLIANT THERAPEUTICS INC | PLRX | 5,750,000 | $85.7M | 2.45% |
| 20 | MIND MEDICINE MINDMED INC | 60255C885 | 6,666,667 | $62.7M | 1.80% |
| 21 | ABIVAX SA | AAVXF | 4,297,438 | $61.5M | 1.76% |
| 22 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,456,053 | $60.5M | 1.73% |
| 23 | IONIS PHARMACEUTICALS INC | IONS | 1,373,475 | $59.5M | 1.71% |
| 24 | APELLIS PHARMACEUTICALS INC | APLS | 1,000,000 | $58.8M | 1.68% |
| 25 | ANI PHARMACEUTICALS INC | ANIP | 822,001 | $56.8M | 1.63% |
| 26 | TRAVERE THERAPEUTICS INC | TVTX | 7,370,000 | $56.8M | 1.63% |
| 27 | VERONA PHARMA PLC | 925050106 | 3,187,415 | $51.3M | 1.47% |
| 28 | KYMERA THERAPEUTICS INC | KYMR | 1,262,246 | $50.7M | 1.45% |
| 29 | INVIVYD INC | IVVD | 10,953,937 | $48.6M | 1.39% |
| 30 | SPYRE THERAPEUTICS INC | SYRE | 1,213,420 | $46.0M | 1.32% |
| 31 | NURIX THERAPEUTICS INC | NRIX | 2,997,830 | $44.1M | 1.26% |
| 32 | HILLEVAX INC | 43157M102 | 2,572,460 | $42.8M | 1.23% |
| 33 | EDITAS MEDICINE INC | EDIT | 5,527,290 | $41.0M | 1.17% |
| 34 | FATE THERAPEUTICS INC | FATE | 5,572,607 | $40.9M | 1.17% |
| 35 | TERNS PHARMACEUTICALS INC | TERN | 6,100,000 | $40.0M | 1.15% |
| 36 | ENGENE HOLDINGS INC | ENGNW | 2,250,000 | $38.1M | 1.09% |
| 37 | TOURMALINE BIO INC | 89157D105 | 1,595,400 | $36.5M | 1.05% |
| 38 | OLEMA PHARMACEUTICALS INC | OLMA | 3,225,419 | $36.5M | 1.05% |
| 39 | SILENCE THERAPEUTICS PLC | SLNCF | 1,643,881 | $35.5M | 1.02% |
| 40 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 7,000,000 | $26.3M | 0.75% |
| 41 | CYBIN INC | HELP | 58,139,535 | $24.0M | 0.69% |
| 42 | ALECTOR INC | ALEC | 3,769,386 | $22.7M | 0.65% |
| 43 | NUVALENT INC | NUVL | 274,512 | $20.6M | 0.59% |
| 44 | AGENUS INC | AGEN | 31,697,539 | $18.4M | 0.53% |
| 45 | PYXIS ONCOLOGY INC | PYXS | 4,184,100 | $17.8M | 0.51% |
| 46 | NEKTAR THERAPEUTICS | NKTR | 18,400,000 | $17.2M | 0.49% |
| 47 | IMMUNOVANT INC | IMVT | 493,352 | $15.9M | 0.46% |
| 48 | NEUMORA THERAPEUTICS INC. | NMRA | 1,000,000 | $13.8M | 0.39% |
| 49 | REPARE THERAPEUTICS INC | 760273102 | 2,684,344 | $12.6M | 0.36% |
| 50 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 175,400 | $12.1M | 0.35% |
| 51 | SCHOLAR ROCK HLDG CORP | SRRK | 680,000 | $12.1M | 0.35% |
| 52 | ANAPTYSBIO INC | ANABV | 529,452 | $11.9M | 0.34% |
| 53 | REGULUS THERAPEUTICS INC | 75915K309 | 3,266,566 | $9.4M | 0.27% |
| 54 | ALTO NEUROSCIENCE INC | ANRO | 600,000 | $9.2M | 0.26% |
| 55 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 167,784 | $7.8M | 0.22% |
| 56 | ZURA BIO LTD | ZURA | 2,523,000 | $6.5M | 0.19% |
| 57 | ALLAKOS INC | 01671P100 | 5,000,000 | $6.3M | 0.18% |
| 58 | ALIGOS THERAPEUTICS INC | ALGS | 6,102,770 | $6.0M | 0.17% |
| 59 | RELMADA THERAPEUTICS INC | RLMD | 1,240,034 | $5.8M | 0.17% |
| 60 | VIGIL NEUROSCIENCE INC | 92673K108 | 1,594,931 | $5.4M | 0.16% |
| 61 | METAGENOMI INC | MGX | 466,232 | $4.9M | 0.14% |
| 62 | SYROS PHARMACEUTICALS INC | 87184Q206 | 828,485 | $4.4M | 0.13% |
| 63 | MERSANA THERAPEUTICS INC | 59045L106 | 579,674 | $2.6M | 0.07% |
| 64 | PRIME MEDICINE INC | PRME | 303,716 | $2.1M | 0.06% |
| 65 | COGENT BIOSCIENCES INC | COGT | 316,000 | $2.1M | 0.06% |
| 66 | STRUCTURE THERAPEUTICS INC | GPCR | 40,137 | $1.7M | 0.05% |